IMMUNOGENETIC DISEASES-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
IMMUNOGENETIC DISEASES-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
批准号:
7725315
负责人:
ELIZABETH K. TAM
金额:
$1.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2009-06-30
关键词:
AllergicApoptosisAsiansAsthmaCell LineCellsCollagenComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDiseaseExtracellular Matrix ProteinsExtrinsic asthmaFibroblastsFundingGene ExpressionGenesGenetic DeterminismGenetic PolymorphismGenetic TranscriptionGoalsGrantGrowth Factor GeneHumanImmunogeneticsInflammationInflammatory ResponseInstitutionInterleukin 4 ReceptorInterleukin-10Interleukin-4LeukocytesMeasuresMyofibroblastNosePacific Island AmericansPathway interactionsPatientsPopulationPredispositionProteinsResearchResearch PersonnelResourcesSourceTissuesUnited States National Institutes of HealthVariantairway remodelingasthmatic patientcytokineinterleukin-10 receptorpromoterreceptorresponse
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这一开发项目的总体目标是了解亚洲人和太平洋岛民哮喘易感性的遗传决定因素,并评估这种易感性对呼吸道重塑的影响。具体地说,我们将在我们的哮喘患者中检验以下假设:
1.白介素4(IL-4)受体和白介素10(IL-10)启动子α链编码基因的变异与T辅助细胞2型(Th2)应答增加有关,Th2应答是哮喘的一种特异性炎症反应。
2.Th2途径的激活与参与成纤维细胞/肌成纤维细胞增殖和激活的基因的差异转录有关,从而导致气道重塑。
3.这些基因的产物在有呼吸道重塑功能证据的哮喘受试者的呼吸道细胞和组织中差异表达。
将通过实现以下具体目标来探索这些假设:
具体目的1:与非过敏性哮喘和哮喘患者相比,确定过敏性哮喘和气道重塑患者外周血白细胞中转录水平最高的细胞因子和生长因子基因。
具体目的2:阐明IL-4受体α和IL-10启动子基因变异之间的关系,并检测哮喘和非哮喘患者Th2途径的激活情况。
具体目标3:鉴定人呼吸道成纤维细胞系和原代培养的人鼻成纤维细胞中与胶原和其他基质蛋白形成有关的基因的基线表达
特定目标4:鉴定和确认编码细胞外基质蛋白的基因或与细胞凋亡相关的基因对特定目标1中确定的细胞因子的转录反应。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The overall goals of this developmental project are to understand the genetic determinants of susceptibility to asthma among Asians and Pacific Islanders and to evaluate the consequences of this susceptibility on airway remodeling. Specifically, we will examine in our population of asthmatics the following hypotheses:
1. Variant polymorphisms in the genes which encode the alpha chain of the interleukin 4 (IL-4) receptor and the interleukin 10 (IL-10) promoter are associated with increased T-helper type 2 (Th2) response, which is a specific inflammatory response to asthma.
2. Activation of the Th2 pathway is associated with differential transcription of genes implicated in fibroblast/myofibroblast proliferation and activation, leading to airway remodeling.
3. Products of these genes are differentially expressed in airway cells and tissues of asthmatic subjects who have functional evidence of airway remodeling.
These hypotheses will be explored by fulfilling the following specific aims:
Specific aim 1: Identify cytokine and growth factor genes that are most highly expressed at the transcriptional level in circulating leukocytes of patients with allergic asthma and airway remodeling, compared to patients who are neither allergic nor asthmatic.
Specific aim 2: Elucidate the association between variants in the IL-4 receptor alpha and IL-10 promoter genes and measure the activation of the Th2 pathway in asthmatic and non-asthmatic patients.
Specific aim 3: Characterize the baseline expression of genes involved in the formation of collagen and other matrix proteins in cultures of human airway fibroblast cell lines and primary cultures of human nasal fibroblasts
Specific aim 4: Characterize and confirm the transcriptional response of genes that encode extracellular matrix proteins or apoptosis-related genes to cytokines identified in specific aim 1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hawaii Island Community Lung Assessment and Scientific Studies (HICLASS)
-
批准号:8662109
-
项目类别:
-
资助金额:$16.65万
-
财政年份:2013
-
负责人:ELIZABETH K. TAM
-
依托单位:
Program to Assess Health Effects Associated with Exposures to Volcanic Emissions
-
批准号:7686379
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASES: CONTROL SUBJECTS
-
批准号:7725314
-
项目类别:
-
资助金额:$1.78万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
Program to Assess Health Effects Associated with Exposures to Volcanic Emissions
-
批准号:8323810
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
Program to Assess Health Effects Associated with Exposures to Volcanic Emissions
-
批准号:8143447
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
Program to Assess Health Effects Associated with Exposures to Volcanic Emissions
-
批准号:7600956
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
Program to Assess Health Effects Associated with Exposures to Volcanic Emissions
-
批准号:7919240
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
Program to Assess Health Effects Associated with Exposures to Volcanic Emissions
-
批准号:8141826
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2008
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASE-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
-
批准号:7609596
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2007
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASES: CONTROL SUBJECTS
-
批准号:7609595
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2007
-
负责人:ELIZABETH K. TAM
-
依托单位:
ACTIVITY 3: IMMUNOGENETIC DISEASES TECHNICAL AND MENTORING CORE
-
批准号:7336068
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2006
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASES: CONTROL SUBJECTS
-
批准号:7380967
-
项目类别:
-
资助金额:$5.31万
-
财政年份:2006
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASE-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
-
批准号:7380968
-
项目类别:
-
资助金额:$5.31万
-
财政年份:2006
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASE-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
-
批准号:7169024
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2005
-
负责人:ELIZABETH K. TAM
-
依托单位:
ACTIVITY 3: IMMUNOGENETIC DISEASES TECHNICAL AND MENTORING CORE
-
批准号:7164341
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2005
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASES: CONTROL SUBJECTS
-
批准号:7169016
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2005
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASES: CONTROL SUBJECTS
-
批准号:7011553
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2004
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASE-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
-
批准号:7011561
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2004
-
负责人:ELIZABETH K. TAM
-
依托单位:
IMMUNOGENETIC DISEASES
-
批准号:6972105
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2004
-
负责人:ELIZABETH K. TAM
-
依托单位:
ACTIVITY 3: IMMUNOGENETIC DISEASES
-
批准号:7011445
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2004
-
负责人:ELIZABETH K. TAM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: